Ruth Arnon

Description

Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of ...

Investor Profile

Ruth Arnon has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Grant (100%)

Country Focus

Israel (100%)

Industry Focus

Financial Services
Management Consulting
Non Profit

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ruth Arnon frequently co-invest with?

Bank Hapoalim

Asia, Tel Aviv, Israel, Tel Aviv

Co-Investments: 1

Vital Capital

Europe, Zurich, Switzerland, Zürich

Co-Investments: 1

Check Point Software Technologies

North America, California, United States, San Carlos

Co-Investments: 1

Which angels does Ruth Arnon often collaborate with?

Israel Makov

Asia, Israel

Shared Deals: 1

Uriel Arnon

Shared Deals: 1

What are some of recent deals done by Ruth Arnon?

Social Finance Israel

Tel Aviv, Tel Aviv, Israel

Social Finance Israel is an impact investment designed to raise private sector capital to fund public programs.

Financial ServicesManagement ConsultingNon Profit

GrantAug 17, 2017

Amount Raised: $20,000,000

Ruth Arnon

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Ruth Arnon frequently co-invest with?

Which angels does Ruth Arnon often collaborate with?

What are some of recent deals done by Ruth Arnon?

Ready to Raise Capital?

Pages

Free tools